Further, serum marker levels were unaltered between patients without pancreatic insufficiency (PI, Figure S2), indicating that the increased expression of TIMP-4 and Endoglin and the decreased expression of PTX3 occur indeed relatively specific for the existence of liver disease without being affected by pancreas and lung disease as other major manifestations of CF. This evidence concerns the gene PTX3 and liver disorder.